Last reviewed · How we verify
Metformin, S-707106 plus metformin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Metformin, S-707106 plus metformin (Metformin, S-707106 plus metformin) — Shionogi.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Metformin, S-707106 plus metformin TARGET | Metformin, S-707106 plus metformin | Shionogi | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Metformin, S-707106 plus metformin CI watch — RSS
- Metformin, S-707106 plus metformin CI watch — Atom
- Metformin, S-707106 plus metformin CI watch — JSON
- Metformin, S-707106 plus metformin alone — RSS
Cite this brief
Drug Landscape (2026). Metformin, S-707106 plus metformin — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-s-707106-plus-metformin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab